Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody.
about
Layilin, a novel integral membrane protein, is a hyaluronan receptorProteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exonCD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factorIdentification of hyaluronic acid binding sites in the extracellular domain of CD44A new spreadsheet method for the analysis of bivariate flow cytometric dataStructural Basis for CD44 Recognition by ERM ProteinsWidespread expression of chondroitin sulfate-type serglycins with CD44 binding ability in hematopoietic cellsCa(2+)/calmodulin-dependent protein kinase mediates the phosphorylation of CD44 required for cell migration on hyaluronanMolecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognitionDevelopment of drug loaded nanoparticles for tumor targeting. Part 1: Synthesis, characterization, and biological evaluation in 2D cell cultures.RHAMM deficiency disrupts folliculogenesis resulting in female hypofertility.CD44 and adhesion of normal and leukemic CD34+ cells to bone marrow stroma.CD44v10 in hematopoiesis and stem cell mobilization.Embryonic neurons of the developing optic chiasm express L1 and CD44, cell surface molecules with opposing effects on retinal axon growthTerminal sialic acids on CD44 N-glycans can block hyaluronan binding by forming competing intramolecular contacts with arginine sidechains.Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesionHyaluronan-CD44 interactions as potential targets for cancer therapy.Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophagesChronic GvHD decreases antiviral immune responses in allogeneic BMT.Cellular CD44S as a determinant of human immunodeficiency virus type 1 infection and cellular tropism.Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44Selective killing of breast cancer cells expressing activated CD44 using CD44 ligand-coated nanoparticles in vitro and in vivoThe cytoplasmic tail of CD44 is required for basolateral localization in epithelial MDCK cells but does not mediate association with the detergent-insoluble cytoskeleton of fibroblasts.Deletions in the cytoplasmic domain of platelet-endothelial cell adhesion molecule-1 (PECAM-1, CD31) result in changes in ligand binding propertiesRegulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons.Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan.Identification of stromal cell products that interact with pre-B cellsCD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma.Regulation of leukocyte rolling and adhesion to high endothelial venules through the cytoplasmic domain of L-selectin.CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation.Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune responseInteraction between CD44 and hyaluronate is directly implicated in the regulation of tumor development.T lymphocytes adhere to airway smooth muscle cells via integrins and CD44 and induce smooth muscle cell DNA synthesisEntry of naive CD4 T cells into peripheral lymph nodes requires L-selectinDefective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain.Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation.Glycosylation of CD44 negatively regulates its recognition of hyaluronan.CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway.A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid.Monoclonal antibodies to CD44 and their influence on hyaluronan recognition.
P2860
Q24291106-DBEEEFF3-81B5-4524-8424-60486908A004Q24651622-03F66A34-B790-4CDE-AF28-56D730C53DBBQ24651739-61D9483F-D12B-44C9-9520-39BBF89BAE8AQ24674652-3F4C6DB1-ED4D-4B4E-88A2-DACFD014F06DQ24791767-D58DC18F-1DE0-4027-B629-41FD90871056Q27651819-2C46422A-D8E8-4665-9C64-6635D62A9E35Q28251584-480CC77A-0BEF-4138-8CA6-7889EBDFD73EQ28344444-210F6700-B0E3-48BD-9EA6-EAED4429FA9BQ28507092-65C8C572-B892-4759-8D67-1EBEC0DD265EQ30607164-06F48B9A-8277-491D-9E64-EF6B4363F375Q30640788-9903603F-4939-4174-8A59-25DCEBF309B8Q33536879-6A4BCD82-6A58-4D5A-9386-996C1FC23682Q34011531-230FF599-4AAC-421C-83AF-759FBE389A35Q34291759-AF42BACA-E6D2-46AF-9A5B-9245D7D0F746Q34389239-1FED9F24-8153-4247-8652-EDBF89DF48C0Q34451438-B2595BCA-C97F-4C37-B6EC-8962B2140186Q35194441-5EA49189-866E-45C9-BA76-5DD90B6BF2DAQ35609982-A81DB708-9589-4FF1-AFFB-1B899FFE1CE1Q35828696-B5A9D71E-EB61-4F18-A5FF-E225FD584A1BQ35840680-180F82CB-274A-45D9-A4A8-004C50FD6B36Q35849305-8395C154-5411-4D22-9E35-D066661A9622Q36021000-A804F19C-C04C-4CA3-A5B5-8C3217D5DC3EQ36233014-2B5A3167-6415-4764-90CC-B14794138384Q36233619-7094A450-5D76-473B-B9FB-D3FE88246359Q36236359-854D5B88-AB98-4C3C-A2C7-A01FB4AFADE2Q36236582-DB07DCF1-6FAF-47E6-8E60-94926CEFFE54Q36237195-90BB1D77-69E9-4549-ACFD-2623D86E46C0Q36237249-36A38FC8-E867-4A53-B028-21E66B451D7FQ36361481-C759D5ED-EE11-4562-B73B-D23930772C72Q36362002-B63F71B8-5370-4F1E-9B59-5EB94CCBBBD5Q36363335-5833EEBD-9A40-4D6E-B6B1-BABDE7CE1096Q36363467-FC07B682-D1FB-4830-B223-443439D979ADQ36363699-EAE1C3FC-F778-476A-8FE8-46A296CD0424Q36364119-24AA08F8-6597-4C1E-BF5B-07EEF104E743Q36364215-1F9CF272-D99E-4338-9B0B-B314DFD257A1Q36365180-C683B288-FDB5-4E8C-AAFB-6D56D76E3853Q36365225-7034D207-AB17-4CE5-A27E-D52210CDFD45Q36365827-779E5E13-BB3B-4794-81AD-E68E7EF7D775Q36366743-DA2F8CF5-0ED0-4921-8EE9-C288288ADAE4Q36382546-5075990D-6F0B-4219-95AC-3C8EF7737926
P2860
Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Requirements for hyaluronic ac ...... in and activation by antibody.
@ast
Requirements for hyaluronic ac ...... in and activation by antibody.
@en
type
label
Requirements for hyaluronic ac ...... in and activation by antibody.
@ast
Requirements for hyaluronic ac ...... in and activation by antibody.
@en
prefLabel
Requirements for hyaluronic ac ...... in and activation by antibody.
@ast
Requirements for hyaluronic ac ...... in and activation by antibody.
@en
P2093
P2860
P356
P1476
Requirements for hyaluronic ac ...... in and activation by antibody.
@en
P2093
P2860
P304
P356
10.1084/JEM.175.1.257
P407
P577
1992-01-01T00:00:00Z